Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -51.01% is in line with its 4-year average of -54.27%, around the middle of its 4-year range (-76.43%–-23.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.82% above its 12-month average of -57.19%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -51.01%.
RETURN ON INVESTED CAPITAL (ROIC)
-51.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-57.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-61.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.82%
CURRENT VS 3Y AVG
+17.48%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-43.09%
vs the sector median at left
AN2 Therapeutics, Inc.
Market Cap
$182.60M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-57.19%
3Y Avg
-61.81%
5Y Avg
N/A
Market Cap
$180.47M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$179.75M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$179.26M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-7.29%
3Y Avg
-11.96%
5Y Avg
-13.56%
Market Cap
$189.11M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-48.91%
3Y Avg
-62.69%
5Y Avg
-47.07%
Market Cap
$190.07M
Return on Invested Capital (ROIC)
-105.17%
TTM Avg
-54.92%
3Y Avg
-54.02%
5Y Avg
-50.29%
Market Cap
$174.27M
Return on Invested Capital (ROIC)
-90.33%
TTM Avg
-95.47%
3Y Avg
-83.14%
5Y Avg
-82.51%
Market Cap
$173.76M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-32.20%
3Y Avg
-32.84%
5Y Avg
-32.70%
Market Cap
$192.49M
Return on Invested Capital (ROIC)
-20.24%
TTM Avg
-14.71%
3Y Avg
-27.01%
5Y Avg
-29.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | $182.60M | -51.01% | -57.19% | -61.81% | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | -9.57% | -477.38% | -295.61% | -295.61% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | -46.59% | -39.23% | -33.74% | -53.74% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | -3.21% | -7.29% | -11.96% | -13.56% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | -74.02% | -48.91% | -62.69% | -47.07% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | -105.17% | -54.92% | -54.02% | -50.29% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -90.33% | -95.47% | -83.14% | -82.51% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -42.61% | -32.20% | -32.84% | -32.70% |
| RxSight, Inc. (RXST)vs › | $192.49M | -20.24% | -14.71% | -27.01% | -29.46% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -8.34% | 4.10% | 3.63% | 7.54% |
ROIC
-51.0%
ROE
-47.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -51.01% |
| 2026-03-31 | -45.31% |
| 2025-12-31 | -71.59% |
| 2025-09-30 | -61.93% |
| 2025-06-30 | -56.12% |
| 2025-03-31 | -68.23% |
| 2024-12-31 | -69.38% |
| 2024-09-30 | -76.43% |
| 2024-06-30 | -72.36% |
| 2024-03-31 | -65.00% |
| 2023-12-31 | -55.84% |
| 2023-09-30 | -45.55% |
| 2023-06-30 | -64.82% |
| 2023-03-31 | -61.34% |
| 2022-12-31 | -44.31% |
| 2022-09-30 | -35.41% |
| 2022-06-30 | -28.09% |
| 2022-03-31 | -23.57% |
| 2021-12-31 | -34.84% |
